Impact of Triple Therapy in Elderly Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

• Antonia Sambola ,

  * E-mail: asambola@vhebron.net

  Affiliation Cardiology Department, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain

  ⨯
• Maria Mutuberría,

  Affiliation Cardiology Department, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain

  ⨯
• Bruno García del Blanco,

  Affiliation Cardiology Department, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain

  ⨯
• Albert Alonso,

  Affiliation Cardiology Department, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain

  ⨯
• José A. Barrabés,

  Affiliation Cardiology Department, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain

  ⨯
• Héctor Bueno,

  Affiliation Cardiology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain

  ⨯
• Fernando Alfonso,

  Affiliation Cardiology Department, Hospital Universitario Clínico San Carlos, Madrid, Spain

  ⨯
• Angel Cequier,

  Affiliation Cardiology Department, Hospital Universitari de Bellvitge, L’Hospitalet del Llobregat, Barcelona, Spain

  ⨯
• Javier Zueco,

  Affiliation Cardiology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain

  ⨯
• Oriol Rodríguez-Leor,

  Affiliation Cardiology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain

  ⨯
• Pilar Tornos,

  Affiliation Cardiology Department, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain

  ⨯
• David García-Dorado

  Affiliation Cardiology Department, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain

  ⨯